Nuveen Asset Management, LLC Nkarta, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 118,486 shares of NKTX stock, worth $290,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,486

Previous 272,396 56.5%

Holding current value

$290,290

Previous $1.61 Million 66.75%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.52 - $8.0 $695,673 - $1.23 Million	-153,910 Reduced 56.5%	118,486 $535,000
Q2 2024 Aug 09, 2024	BUY	$5.27 - $10.82 $207,142 - $425,290	39,306 Added 16.86%	272,396 $1.61 Million
Q1 2024 May 13, 2024	BUY	$5.59 - $15.71 $789,095 - $2.22 Million	141,162 Added 153.56%	233,090 $2.52 Million
Q4 2023 Feb 14, 2024	BUY	$1.31 - $6.6 $13,800 - $69,531	10,535 Added 12.94%	91,928 $606,000
Q3 2023 Nov 14, 2023	SELL	$1.39 - $2.29 $562,255 - $926,305	-404,500 Reduced 83.25%	81,393 $113,000
Q2 2023 Aug 14, 2023	SELL	$2.19 - $5.17 $5,321 - $12,563	-2,430 Reduced 0.5%	485,893 $1.06 Million
Q1 2023 May 15, 2023	SELL	$3.37 - $6.3 $922,342 - $1.72 Million	-273,692 Reduced 35.92%	488,323 $1.73 Million
Q4 2022 Feb 14, 2023	BUY	$5.14 - $14.35 $367,998 - $1.03 Million	71,595 Added 10.37%	762,015 $4.56 Million
Q3 2022 Nov 14, 2022	BUY	$12.27 - $18.39 $4.17 Million - $6.25 Million	339,858 Added 96.95%	690,420 $9.09 Million
Q2 2022 Aug 15, 2022	BUY	$7.77 - $19.44 $2.27 Million - $5.67 Million	291,734 Added 495.91%	350,562 $4.32 Million
Q1 2022 May 16, 2022	BUY	$8.66 - $14.99 $4,849 - $8,394	560 Added 0.96%	58,828 $679,000
Q4 2021 Feb 14, 2022	SELL	$12.79 - $26.88 $53,679 - $112,815	-4,197 Reduced 6.72%	58,268 $772,000
Q3 2021 Nov 12, 2021	SELL	$26.67 - $38.76 $531,799 - $772,874	-19,940 Reduced 24.2%	62,465 $1.96 Million
Q2 2021 Aug 16, 2021	SELL	$23.94 - $36.68 $245,289 - $375,823	-10,246 Reduced 11.06%	82,405 $2.61 Million
Q1 2021 May 17, 2021	BUY	$31.33 - $59.61 $738,354 - $1.4 Million	23,567 Added 34.11%	92,651 $3.05 Million
Q4 2020 Feb 16, 2021	BUY	$27.03 - $75.62 $151,719 - $424,455	5,613 Added 8.84%	69,084 $4.25 Million
Q3 2020 Nov 16, 2020	BUY	$23.52 - $47.9 $1.49 Million - $3.04 Million	63,471 New	63,471 $1.91 Million

Others Institutions Holding NKTX

# of Institutions

129

Shares Held

66.5M

Call Options Held

173K

Put Options Held

20K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $119M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Nkarta, Inc. Transaction History